Group 1 - Xenon (NASDAQ: XENE) is nearing completion of its phase 3 X-TOLE2 trial for its Kv7 potassium channel opener azetukalner, aimed at treating patients with focal onset seizures (FOS) [2] - The Biotech Analysis Central service offers a comprehensive analysis of over 600 biotech investing articles and a model portfolio of more than 10 small and mid-cap stocks [2] - The service is available for $49 per month, with a yearly plan offering a 33.50% discount, bringing the price to $399 per year [1]

Core Viewpoint - SRx Health Solutions, Inc. announced that its subsidiary, SRx Health Solutions (Canada), Inc., has obtained an Initial Order under the Companies' Creditors Arrangement Act in Canada, allowing for restructuring and financing to stabilize operations and explore potential sales of its business or assets [1][2]. Group 1: Initial Order and CCAA Proceedings - The Ontario Superior Court of Justice granted an Initial Order for SRx Canada under the CCAA, enabling the company to restructure its operations [1][2]. - The Initial Order includes a stay of proceedings in favor of SRx Canada and the appointment of Grant Thornton Limited as the Monitor [6]. Group 2: Financing and Operations - SRx Canada has secured debtor-in-possession (DIP) financing of up to $1,750,000, which will be used for working capital needs and to support ongoing operations during the restructuring process [2][6]. - The DIP financing is expected to provide the necessary time and stability for SRx Canada to complete a Sale Process, which may involve selling all or substantially all of its business or assets [2]. Group 3: Company Overview - SRx Health Solutions, Inc. is a leading integrated healthcare services provider in Canada, operating across all ten provinces and focusing on specialty healthcare services [4]. - The company combines industry knowledge, technology, and a patient-centric approach to enhance patient care and wellness initiatives in Canada [4].

Blue Ridge Bankshares (NYSE: BRBS ) is a small bank in Virginia that is trading at a relatively low valuation, but the bank has some issues to fix and therefore is a risky investment for long-term investors right now.Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio management. Associated with the existing autho ...

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or a ...

CoreWeave Inc CRWV has been riding a strong upward current this year, surging more than 250% year-to-date and steadily climbing through the summer months. Now, as it prepares to report second quarter earnings Tuesday, investors are eager to see if this cloud infrastructure leader can keep its bullish streak alive — or if some turbulence lies ahead.Track CRWV stock here.Read Also: CoreWeave Stock Ramps 30% Into Q2 Earnings: Here’s What To WatchBullish Momentum In The CloudsChart created using Benzinga ProAt ...

CAVA Group, Inc. CAVA will release earnings results for the second quarter, after the closing bell on Tuesday, Aug. 12.Analysts expect the Washington, District of Columbia-based company to report quarterly earnings at 13 cents per share, down from 17 cents per share in the year-ago period. CAVA Group projects to report quarterly revenue at $285.23 million, compared to $233.5 million a year earlier, according to data from Benzinga Pro.On Aug. 8, CAVA opened its first Pittsburgh restaurant, located at 3619 Fo ...

Lumentum Holdings Inc. LITE will release earnings results for the fourth quarter, after the closing bell on Tuesday, Aug. 12.Analysts expect the San Jose, California-based company to report quarterly earnings at 81 cents per share, up from 6 cents per share in the year-ago period. Lumentum projects to report quarterly revenue at $469.92 million, compared to $308.3 million a year earlier, according to data from Benzinga Pro.On Aug. 7, Lumentum announced the expansion of its U.S.-based semiconductor facility. ...

Circle Internet Group, Inc. CRCL posted stand-out second-quarter financial results on Tuesday in its first earnings report as a publicly traded company. CRCL stock climbs after Q2 earnings. See the chart here. The Surge Of USDC: A Game ChangerOn the company's earnings call with investors and analysts, CEO Jeremy Allaire highlighted the growth of Circle's USDC USDC/USD stablecoin to $61.3 billion in circulation as of June 30. Read Next: Retail Crowd’s Top Stocks With Earnings This Week: Archer, Rigetti, Oklo ...

When I last wrote about the biotech stock Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) a month ago, its price had declined by ~20%. This is exactly the extent of correction I had forecast for it, but with a difference. I had expected the decline toManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. ...

U.S. President Donald Trump (L) invites Nvidia CEO Jensen Huang to speak in the Cross Hall of the White House during an event on "Investing in America" on April 30, 2025 in Washington, DC.The Trump administration is still working out the details of its 15% export tax on Nvidia and AMD and could bring deals of this kind to more companies, the White House's Karoline Leavitt said Tuesday."Right now it stands with these two companies. Perhaps it could expand in the future to other companies," said Leavitt, the ...